skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design

Journal Article · · Journal of Virology
DOI:https://doi.org/10.1128/JVI.03246-15· OSTI ID:1314247

Extraordinary antibodies capable of near pan-neutralization of HIV-1 have been identified. One of the broadest is antibody 10E8, which recognizes the membrane-proximal external region (MPER) of the HIV-1 envelope and neutralizes >95% of circulating HIV-1 strains. If delivered passively, 10E8 might serve to prevent or treat HIV-1 infection. Antibody 10E8, however, is markedly less soluble than other antibodies. Here, we describe the use of both structural biology and somatic variation to develop optimized versions of 10E8 with increased solubility. From the structure of 10E8, we identified a prominent hydrophobic patch; reversion of four hydrophobic residues in this patch to their hydrophilic germ line counterparts resulted in an ~10-fold decrease in turbidity. We also used somatic variants of 10E8, identified previously by next-generation sequencing, to optimize heavy and light chains; this process yielded several improved variants. Of these, variant 10E8v4 with 26 changes versus the parent 10E8 was the most soluble, with a paratope we showed crystallographically to be virtually identical to that of 10E8, a potency on a panel of 200 HIV-1 isolates also similar to that of 10E8, and a half-life in rhesus macaques of ~10 days. An anomaly in 10E8v4 size exclusion chromatography that appeared to be related to conformational isomerization was resolved by engineering an interchain disulfide. Furthermore, by combining a structure-based approach with natural variation in potency and solubility from the 10E8 lineage, we successfully created variants of 10E8 which retained the potency and extraordinary neutralization breadth of the parent 10E8 but with substantially increased solubility.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
W-31-109-Eng-38
OSTI ID:
1314247
Journal Information:
Journal of Virology, Vol. 90, Issue 13; ISSN 0022-538X
Publisher:
American Society for MicrobiologyCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 53 works
Citation information provided by
Web of Science

References (41)

Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope journal September 2004
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1 journal July 2014
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody journal September 2012
Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo journal August 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface journal September 2014
Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region journal December 2009
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 journal April 2015
Coot model-building tools for molecular graphics journal November 2004
Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41 journal February 2005
Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 journal November 2001
Enhanced antibody half-life improves in vivo activity journal January 2010
Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features journal December 1983
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals journal January 2010
Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41 journal November 2013
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection journal December 2015
Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1 journal May 2002
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers journal May 2014
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
HIV-1 Broadly Neutralizing Antibody Extracts Its Epitope from a Kinked gp41 Ectodomain Region on the Viral Membrane journal January 2008
Structural Basis of Enhanced Binding of Extended and Helically Constrained Peptide Epitopes of the Broadly Neutralizing HIV-1 Antibody 4E10 journal February 2007
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys journal October 2013
HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission journal April 2014
Enhancing Protein Crystallization through Precipitant Synergy journal September 2003
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex journal November 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection journal August 2014
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer journal March 2016
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies journal September 2012
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 journal July 2010
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization journal October 2011
Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline journal January 2014
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults: VRC01 HIV-1 mAb in healthy adults journal September 2015
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies journal March 2014
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor journal July 2014
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection journal April 2015
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Somatic Hypermutation Shapes the Antibody Repertoire of Memory B Cells in Humans journal August 2001
Phaser crystallographic software journal July 2007
Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6 journal December 2013
Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains journal March 2013

Cited By (7)

Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity journal February 2018
Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions journal January 2019
The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody journal January 2020
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma journal January 2017
Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope journal October 2019
Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice journal January 2020
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41 journal August 2019